Power Law company profile

Areteia Therapeutics

Biotech & Life Sciences · Chapel Hill, United States · Founded 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Investors

11 investors on Areteia Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 11 investors entered at this stage

Maverick Capital

Marshall Wace

Saturn Partners

ARCH Venture Partners

Population Health Partners

Bain Capital Life Sciences

Sanofi

Viking Global Investors

Activate Venture Partners

Access Biotechnology

Global footprint

Where Areteia Therapeutics has talent and traffic

Web traffic by country

2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$13M patent portfolio · 17 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$13M

0.77% of valuation · 2.4× smaller than top peer Dynavax Technologies ($32M)

17 active patent families

Where Areteia Therapeutics innovates DexpramipexoleBenzothiazoleGranulocytic cellsPharmaceutical medicineEosinophil

Tech-focus vs peers

Where Areteia Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Areteia Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Areteia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo